| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.37 | 3e-17 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.25 | 7e-09 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |